Aurinia Pharmaceuticals Inc (AUPH) 20 Days SMA touches -1.40%: The odds favor the bear
On Tuesday, Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) was -0.79% down from the session before settling in for the closing price of $5.04. A 52-week range
On Tuesday, Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) was -0.79% down from the session before settling in for the closing price of $5.04. A 52-week range
Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) kicked off on Tuesday, up 2.61% from the previous trading day ,before settling in for the closing price of $4.98.
Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) open the trading on Thursday, with a bit cautious approach as it glided -1.74% to $5.09, before settling in for
Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) on Monday, soared 7.78% from the previous trading day, before settling in for the closing price of $5.01. Within the
Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) established initial surge of 1.42% at $5.00, before settling in for the price of $4.93 at the close. Taking a
Witnessing the stock’s movement on the chart, on May 25, 2023, Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) had a quiet start as it plunged -8.43% to
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.